Literature DB >> 2155877

Unusual manifestations of Epstein-Barr virus encephalomyelitis.

R R McKendall1, S A Sadiq, J R Calverley.   

Abstract

A patient with atypical manifestations of Epstein-Barr Virus (EBV) encephalomyelitis is presented. The patient had unusual spinal fluid immunoglobulin abnormalities, the syndrome of inappropriate anti-diuretic hormone secretion, autonomic dysfunction and spinal arachnoiditis. The cisternal CSF, with a very high IgG level (34.3 mg/dl; normal less than 6.1) but a normal albumin content, displayed evidence of massive intrathecal immunoglobulin production. This was further confirmed by the presence of oligoclonal bands. These clinical manifestations have not previously been reported in encephalomyelitis associated with EBV infection.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2155877     DOI: 10.1007/BF01644180

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  10 in total

1.  HYPONATREMIA WITH HERPES SIMPLEX ENCEPHALITIS. POSSIBLE RELATIONSHIP OF LIMBIC LESIONS AND ADH SECRETION.

Authors:  R L ROVIT; M H SIGLER
Journal:  Arch Neurol       Date:  1964-06

Review 2.  A new approach to the study of human B lymphocyte function using an indirect plaque assay and a direct B cell activator.

Authors:  A G Bird; S Britton
Journal:  Immunol Rev       Date:  1979       Impact factor: 12.988

3.  Autoantibody to "intermediate filament" in infectious mononucleosis.

Authors:  E Linder; P Kurki; L C Andersson
Journal:  Clin Immunol Immunopathol       Date:  1979-12

4.  Pathophysiology of epidemic St. Louis encephalitis. I. Inappropriate secretion of antidiuretic hormone. II. Pituitary-adrenal function. 3. Cerebral blood flow and metabolism.

Authors:  M G White; N W Carter; F C Rector; D W Seldin; S J Drewry; J P Sanford; J P Luby; R H Unger; N M Kaplan; W Shapiro; S Eisenberg
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

5.  IgG synthesis within the central nervous system. Comparison of three formulas.

Authors:  E A Schuller; S Benabdallah; H J Sagar; J A Reboul; L C Tömpe
Journal:  Arch Neurol       Date:  1987-06

6.  Recurrent cerebellitis. A case report of a possible relationship with Epstein-Barr infection.

Authors:  H Shoji; Y Goto; Y Yanase; Y Sato; K Nakashima; H Natori; M Kaji
Journal:  Kurume Med J       Date:  1983

7.  Pleocytosis and immunoglobulin changes in cerebrospinal fluid and herpesvirus serology in patients with Guillain-Barré syndrome.

Authors:  H Link; B Wahren; E Norrby
Journal:  J Clin Microbiol       Date:  1979-03       Impact factor: 5.948

8.  Prolonged atypical illness associated with serological evidence of persistent Epstein-Barr virus infection.

Authors:  M Tobi; A Morag; Z Ravid; I Chowers; V Feldman-Weiss; Y Michaeli; E Ben-Chetrit; M Shalit; H Knobler
Journal:  Lancet       Date:  1982-01-09       Impact factor: 79.321

9.  Syndrome of inappropriate secretion of antidiuretic hormone in enteroviral meningitis.

Authors:  S Chemtob; E R Reece; E L Mills
Journal:  Am J Dis Child       Date:  1985-03

10.  Epstein-Barr virus antibodies in neurological diseases.

Authors:  S Yabuki; Y Kazahaya; I Kubonishi
Journal:  Folia Psychiatr Neurol Jpn       Date:  1985
  10 in total
  3 in total

1.  Epstein-barr virus: an unusual cause of cholestatic hepatitis in older adults.

Authors:  Andelka D Losavio; Helen S Te
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

2.  Comment on unusual manifestations of Epstein-Barr virus (EBV) encephalomyelitis (Infection 18, 1990, 33-35)

Authors:  A Lopez-Navidad; P Domingo
Journal:  Infection       Date:  1991 Jan-Feb       Impact factor: 3.553

Review 3.  The leptomeninges as a critical organ for normal CNS development and function: First patient and public involved systematic review of arachnoiditis (chronic meningitis).

Authors:  Carol S Palackdkharry; Stephanie Wottrich; Erin Dienes; Mohamad Bydon; Michael P Steinmetz; Vincent C Traynelis
Journal:  PLoS One       Date:  2022-09-30       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.